⌘K

Login Start Free

Home/Filings/4/0001209191-16-093488

4//SEC Filing

Anacor Pharmaceuticals, Inc. 4

Accession 0001209191-16-093488

CIK 0001411158operating

View on SEC.gov Company Profile

Filed

Jan 24, 7:00 PM ET

Accepted

Jan 25, 9:01 PM ET

Size

6.9 KB

Accession

0001209191-16-093488

Insider Transaction Report

Form 4

Period: 2016-01-22

Anacor Pharmaceuticals, Inc.ANAC

VP, Clinical Dev & Interim CMO

Transactions

Exercise/Conversion
Stock Option (right to buy)
2016-01-22−11,800→ 0 total
Exercise: $7.55Exp: 2020-08-20→ Common Stock (11,800 underlying)
Exercise/Conversion
Common Stock
2016-01-22$7.55/sh+11,800$89,090→ 39,081 total

Footnotes (1)

[F1]This option is fully vested and exercisable.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Anacor Pharmaceuticals, Inc.

CIK 0001411158

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001411158

Filing Metadata

Form type: 4
Filed: Jan 24, 7:00 PM ET
Accepted: Jan 25, 9:01 PM ET
Size: 6.9 KB

View on SEC.gov